Global Needle-Free Drug Delivery Market Analysis, Market Size, Market Growth, Competitive Strategies, and Worldwide Demand 2027

Global Needle-Free Drug Delivery Market Research report consolidates investigation of significant market players. It sets down shares of every player inside market, development rate and market engaging quality in various end clients/locales. Our exact investigation on the Global Needle-Free Drug Delivery Market encourages a client to settle on a suitable choice as a way to extend their market nearness and increment their market presence and increase their market share. This report market intelligence in the most detailed way. The Global Needle-Free Drug Delivery Market report structure has been made in such a way that it offers business value to the maximum extent. It provides crucial insights into the market dynamics that further allows strategic decision-making for the market players present as well as the market entrants.

Global Needle-Free Drug Delivery Market is expected to rise from its initial estimated value of USD 8.15 billion by 2018 to an estimated value of USD 17.42 billion by 2026, registering a CAGR of 9.95% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing prevalence of diabetes and chronic diseases, and demand for pain-free delivery of drugs.

Download PDF Sample Copy of Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-needle-free-drug-delivery-market

Global Needle-Free Drug Delivery Market Segmentation:-

By Technology (Inhaler, Novel Needle-Free, Jet Injector, Transdermal Patch, Others),
Application (Insulin Delivery, Vaccination, Pediatric Injections, Pain Management, Others),
Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
Competitive Analysis: Global Needle-Free Drug Delivery Market

Global needle-free drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of needle-free drug delivery market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Market Drivers:

High amount of prevalence of diabetes worldwide is expected to drive the market growth
Reduction in risk of transferring of infection and pain associated with normal needle delivery methods is also expected to drive the market growth
Market Restraints:

Limitations and drawbacks associated with the devices like, blockage and restrictions of flow of drugs is due to the tissue getting stuck in the needle openings is expected to restrain the market growth
High cost of these devices is also expected to restrain the market growth
Reasons to Purchase this Report:

Current and future of global needle-free drug delivery market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Key Developments in the Market:

In October 2017, Antares Pharma announced the establishment of an agreement with Ferring B.V., for the sale of rights and assets related to “ZOMAJET” (needle-free auto injector device).
In May 2018, Namaste Technologies Inc., announced an agreement with Inolife Sciences for the commercialization and application of Inolife’s needle-free technology in delivery of medical cannabis.

To Inquire before Buy Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-needle-free-drug-delivery-market

Market Definition: Global Needle-Free Drug Delivery Market

Needle-free drug delivery systems are an innovative way and method of delivery of drugs and other types of medicines. They can also be forms of transdermal patches, inhaling systems or even micro-needles that do not pierce the skin like a conventional needle.

According to International Diabetes Federation and World Health Organization, there are around 425 million people with diabetes globally, and this number is expected to rise to around 629 million globally. This high number of diabetes ridden population is expected to act as a major driver for the market growth due to the requirement of insulin delivery devices that are pain-free, and needle-free.

Key Market Competitors: Global Needle-Free Drug Delivery Market

Few of the major competitors currently working in the needle-free drug delivery market are

Antares Pharma,
Tianjin Xuying Technology Development Co. Ltd.,
Verdict Media Limited,
3M, PharmaJet,
Zogenix,
Inovio Pharmaceuticals Inc.,
Valeritas Inc,
Akra Dermo-Jet,
D’Antonio Consultants International Inc.,
Endo Pharmaceuticals Inc., BD,
CROSSJECT,
MIT Canada,
MedImmune,
Mystic Pharmaceuticals,
Needle Free Injection System,
Inolife Sciences,
Ferring B.V.,
OptiNose US Inc., and Pfizer Inc.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.